NCADD-NJ Advocacy Leadership Program


 

NCADD-NJ Advocacy Leadership Program – The Advocacy Leadership Program aims to develop highly knowledgeable and trained citizens of New Jersey, especially those most impacted or affected by alcohol and drug addiction, who will contribute significantly by participating in policy decisions that influence the treatment and prevention of, as well as recovery from, alcohol and drug addiction. The issues at the forefront of the Program are closing the states addiction treatment gap; ending the stigmatization of addiction by promoting recovery; ending discrimination experienced by persons in recovery; and, preventing addiction. The Program will foster engaged and educated advocates by building an understanding of self-advocacy, legislative / government processes, social change models, story-telling, as well as how to use social capital as a way of influencing others to take action. The ultimate goal is to have Advocacy Leaders become fully empowered advocates engaged in systems change efforts via core leadership teams established throughout New Jersey.

 

Dr. Edward Hallowell Sheds Light on ADHD

Filed under: drug treatment programs nj

The drug helped the kids interact and it was soon referred to as the “arithmetic pill” because they were now able to do their math. Research continued and ADHD started being called … Millburn's First Community Big Read Goes Off Without a Hitch …
Read more on TheAlternativePress.com (press release) (blog)

 

Rutgers chemist's HIV research is step toward solving human puzzle

Filed under: drug treatment programs nj

The Centers for Disease Control and Prevention estimates that 1.1 million U.S. residents are living with HIV. New Jersey has the nation's fourth-highest rate of HIV among adults and the second-highest rate among children. According to the United …
Read more on The Star-Ledger – NJ.com

 

New Rx for Advanced Multiple Myeloma

Filed under: drug treatment programs nj

Richard Pazdur, MD, director of the Office of Hematology and Oncology Products in FDA's Center for Drug Evaluation and Research, said, “Treatment for multiple myeloma is tailored to meet individual patient's needs, and today's approval provides an …
Read more on dailyRx

 

Smoking, Once Used to Reward, Faces a Ban in Mental Hospitals

Filed under: drug treatment programs nj

A report by the National Association of State Mental Health Program Directors said data suggested that people with the most serious mental illnesses die on average 25 years earlier than the general population, with many from smoking-exacerbated …
Read more on New York Times